NCT01959555已完成不适用
Project to Update the Study of Congenital Haemophilia in Spain
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,157
- 主要终点
- Severity (mild, moderate or severe) of congenital haemophilia A and B in Spain during 2013, described as proportion (%) per category of the total number of patients with haemophilia A or B
研究概览
简要总结
This study is conducted in Europe. The aim of the study is to update the knowledge about the prevalence and severity of congenital haemophilia (A and B) in Spain.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
- •Male patients of any age diagnosed with congenital haemophilia A or B who visited their HTC at least once during the period of January 2013 to December 2013
排除标准
- •Previous participation in this study
- •Female patients
- •Acquired haemophilia
结局指标
主要结局
Severity (mild, moderate or severe) of congenital haemophilia A and B in Spain during 2013, described as proportion (%) per category of the total number of patients with haemophilia A or B
时间窗: Assessed at study visit (day 1)
Prevalence of congenital haemophilia A and B in Spain in 2013, described as proportion (%) of patients in the total population (extracted from the last available census of the Spanish population for the regions considered for the study)
时间窗: Assessed at study visit (day 1)
次要结局
- Mean current age at the time of visit to the HTC in 2013(Assessed at study visit (day 1))
- Proportion (%) of patients with/without genetic screening performed(Assessed at study visit (day 1))
- Proportion (%) of patients who received on demand or prophylaxis treatment(Assessed at study visit (day 1))
- Proportion (%) of patients with HIV (Human immunodeficiency virus)(Assessed at study visit (day 1))
- Proportion (%) of patients with presence of inhibitors(Assessed at study visit (day 1))
- Proportion (%) of patients with immune tolerance induction treatment performed(Assessed at study visit (day 1))
- Total number of surgery interventions performed(ThAssessed at study visit (day 1))
- Mean number of days of absenteeism from work in 2013(Assessed at study visit (day 1))
- Proportion (%) of patients who needed support of a reference Haemophilia Healthcare Centre in 2013(Assessed at study visit (day 1))
- Proportion (%) of patients who received plasmatic or recombinant treatment(Assessed at study visit (day 1))
- Mean number of bleeding episodes(Assessed at study visit (day 1))
- Mean number of joint bleeds(Assessed at study visit (day 1))
- Proportion (%) of patients with infectious complications(Assessed at study visit (day 1))
- Proportion (%) of patients with quality of life questionnaire (QoLQ) performed in 2013(Assessed at study visit (day 1))
- Mean number of days of absenteeism to school/university in children and adolescents in 2013(Assessed at study visit (day 1))
- Proportion (%) of patients with treatment administered at home(Assessed at study visit (day 1))
- Mean age at diagnosis(Assessed at study visit (day 1))
- Proportion (%) of patients with established arthropathy(Assessed at study visit (day 1))
研究者
相似试验
已完成
不适用
Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia DatabaseCongenital Bleeding DisorderHaemophilia AHaemophilia BNCT00853086Novo Nordisk A/S139
已完成
不适用
Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired HaemophiliaAcquired Bleeding DisorderAcquired HaemophiliaNCT01285089Novo Nordisk A/S21
招募中
不适用
HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV CoinfectionHepatitis DNCT06264583University Hospital, Bonn8,000
招募中
不适用
The European Paediatric Network for Haemophilia Management ( PedNet Registry)Factor VIII DeficiencyFactor IX DeficiencyNCT02979119PedNet Haemophilia Research Foundation4,000
已完成
不适用
Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)PregnancyNeonatesNCT00724789Organon and Co2,066